Characteristics and resource utilization of high-cost users in the intensive care unit: a population-based cohort

Claudia Dziegielewski1, Robert Talarico2, Haris Imsirovic2

  • 1Department of Medicine, University of Ottawa, Ontario, Ottawa, Canada. cldziegielewski@toh.ca.

Insights

High-cost users in intensive care units (ICUs) have longer stays and higher costs, despite lower in-hospital mortality. Identifying these high-cost patients is key to reducing healthcare spending.

Area of Science:

  • Healthcare Economics
  • Critical Care Medicine
  • Health Services Research

Background:

  • Intensive care unit (ICU) healthcare expenditure represents a significant financial burden.
  • Identifying high-cost users is a potential strategy for cost reduction in healthcare.
  • Understanding the characteristics and outcomes of high-cost ICU patients is crucial for targeted interventions.

Purpose of the Study:

  • To describe the characteristics of high-cost users admitted to the ICU.
  • To analyze the health outcomes associated with high-cost ICU utilization.
  • To investigate the cost patterns of high-cost users in the ICU.

Main Methods:

  • A population-based retrospective cohort study was conducted using data from Ontario ICUs between 2011 and 2018.
  • High-cost users were defined as those in the upper 10th percentile of total healthcare costs in the year following ICU admission.
  • Patient characteristics, length of stay, mortality, disposition, and costs were compared between high-cost and non-high-cost user groups.

Main Results:

  • The study included 370,061 patients, with 37,006 identified as high-cost users.
  • High-cost users had longer ICU lengths of stay (22.4 days vs. 5.56 days) and higher total healthcare costs ($238,231 vs. $45,155).
  • High-cost users exhibited lower in-hospital mortality (10.0% vs. 14.2%) but increased non-home disposition (77.4% vs. 42.2%).

Conclusions:

  • High-cost users in the ICU are characterized by extended stays, lower in-hospital mortality, and substantially higher overall healthcare costs.
  • These high-cost users accounted for a disproportionate 37.0% of total healthcare costs.
  • Further research into cost patterns and predictors of high-cost ICU users is essential for developing effective cost-reduction strategies.
Abstract

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
654
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
422
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
16
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
67
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41